Dobutamine Hydrochloride

CHEMBL1200418 Phase 4 Aprovado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
337.8 g/mol
LogP
Phase
4

The hydrochloride salt form of dobutamine, the standard preparation used in intravenous infusions for the treatment of severe heart failure and cardiac stress testing. It increases the force of heart contractions by stimulating cardiac beta-1 receptors. Continuous ECG monitoring is required during administration.

Peso Molecular

337,8000 g/mol

TPSA

72,70 Ų

Áreas Terapêuticas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1.Cl

InChI

InChI=1S/C18H23NO3.ClH/c1-13(2-3-14-4-7-16(20)8-5-14)19-11-10-15-6-9-17(21)18(22)12-15;/h4-9,12-13,19-22H,2-3,10-11H2,1H3;1H

Molecular Formula

C18H24ClNO3

HBD / HBA

5 / 4

Ligações Rotacionáveis

7

Átomos Pesados

23

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

The hydrochloride salt form of dobutamine, the standard preparation used in intravenous infusions for the treatment of severe heart failure and cardiac stress testing. It increases the force of heart contractions by stimulating cardiac beta-1 receptors. Continuous ECG monitoring is required during administration.

Yes, Dobutamine Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200418. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 65324. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.